Cervical insufficiency (CI) is associated with intra‐amniotic infection or inflammation. Antimicrobial peptides (AMPs) in amniotic fluid may protect the fetus against microbial invasion, giving their broad‐spectrum microbiocidal properties. We evaluated… Click to show full abstract
Cervical insufficiency (CI) is associated with intra‐amniotic infection or inflammation. Antimicrobial peptides (AMPs) in amniotic fluid may protect the fetus against microbial invasion, giving their broad‐spectrum microbiocidal properties. We evaluated changes in amniotic fluid AMP expression in women with CI and assessed whether these changes are related to their pregnancy outcomes.
               
Click one of the above tabs to view related content.